The generic name for Solifenacin succinate is solifenacin [1].
When Did Solifenacin Become Available as a Generic?
The patent for Solifenacin succinate expired in December 2023 [2]. This expiration allows for the availability of generic versions of the drug.
What is Solifenacin Used For?
Solifenacin is a medication used to treat overactive bladder (OAB) with symptoms of urinary urgency, frequency, and incontinence [1]. It works by relaxing the bladder muscle, which helps to reduce the urge to urinate [1].
How Does Solifenacin Compare to Other OAB Treatments?
Solifenacin is a muscarinic antagonist, a class of drugs that includes other OAB medications like oxybutynin, tolterodine, and darifenacin [3]. These medications differ in their effectiveness, side effect profiles, and dosing schedules. Patients and healthcare providers consider these factors when choosing the most suitable treatment [3].
What Are the Potential Side Effects of Solifenacin?
Common side effects of solifenacin can include dry mouth, constipation, blurred vision, and indigestion [1]. Less common but more serious side effects may also occur [1].
What Companies Are Involved in Solifenacin Production?
The original innovator of Solifenacin succinate was Astellas Pharma [4]. Following patent expiration, various pharmaceutical companies are expected to produce and market generic versions of solifenacin. Information on specific generic manufacturers can often be found through pharmaceutical databases and regulatory filings. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can indicate upcoming generic competition [5].